Evaluation of the Antiviral Efficacy of Subcutaneous Nafamostat Formulated with Glycyrrhizic Acid against SARS-CoV-2 in a Murine Model

The ongoing COVID-19 pandemic highlights the urgent need for effective antiviral agents and vaccines. Drug repositioning, which involves modifying existing drugs, offers a promising approach for expediting the development of novel therapeutics. In this study, we developed a new drug, MDB-MDB-601a-NM...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Ju Hwan, Lee, Woong Hee, Min, Seong Cheol, Kim, Beom Kyu, Park, On Bi, Chokkakula, Santosh, Ahn, Seong Ju, Oh, Sol, Park, Ji-Hyun, Jung, Ji Won, Jung, Ji Min, Kim, Eung-Gook, Song, Min-Suk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253381/
https://www.ncbi.nlm.nih.gov/pubmed/37298530
http://dx.doi.org/10.3390/ijms24119579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253381/
https://www.ncbi.nlm.nih.gov/pubmed/37298530
http://dx.doi.org/10.3390/ijms24119579

Ejemplares similares